ASPARAGINASE-SPECIFIC ANTIBODY MEASUREMENT IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) UNDER NATIVE E. COLI ASPARAGINASE-BASED AND ITS POTENTIAL FACTORS ASSOCIATION

被引：0
|
作者：
Techavichit, Piti [1 ]
Chaweephisal, Phumin [1 ]
Poparn, Hansamon [1 ]
Chiengthong, Kanhatai [1 ]
Lauhasurayotin, Supanun [1 ]
Sosothikul, Darintr [1 ]
机构：
[1] Dept Pediat, Integrat & Innovat Hematol Oncol Res Unit, Bangkok, Thailand
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP072
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Hypersensitivity Reactions to Native E. coli L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction
    Moericke, Anja
    Rizzari, Carmelo
    Alten, Julia
    Attarbaschi, Andishe
    Beier, Rita
    Biondi, Andrea
    Burkhardt, Birgit
    Bodmer, Nicole
    Boos, Joachim
    Cario, Gunnar
    Conter, Valentino
    Flotho, Christian
    Kulozik, Andreas
    Lanvers-Kaminsky, Claudia
    Mann, Georg
    Niggli, Felix
    Silvestri, Daniela
    von Stackelberg, Arend
    Stanulla, Martin
    Valsecchi, Maria-Grazia
    Schrappe, Martin
    Zimmermann, Martin
    HEMASPHERE, 2023, 7 (06):
  • [32] Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study
    Liu, Wen-jian
    Wang, Hua
    Wang, Wei-da
    Zhu, Meng-yuan
    Liu, Cheng-cheng
    Wang, Jing-hua
    Lu, Yue
    SCIENTIFIC REPORTS, 2016, 6
  • [33] Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study
    Wen-jian Liu
    Hua Wang
    Wei-da Wang
    Meng-yuan Zhu
    Cheng-cheng Liu
    Jing-hua Wang
    Yue Lu
    Scientific Reports, 6
  • [34] Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. coli-derived asparaginase
    Figueiredo, Lisa
    Cole, Peter D.
    Drachtman, Richard A.
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (03) : 227 - 234
  • [35] Hypersensitivity Reactions to Native E. coli L-Asparaginase in Children with Acute Lymphoblastic Leukemia May Vary By Treatment Schedule and Type of Glucocorticoid in Induction: Results of Trial ALL-BFM 2000
    Moericke, Anja
    Schrappe, Martin
    Rizzari, Carmelo
    Alten, Julia
    Attarbaschi, Andishe
    Beier, Rita
    Biondi, Andrea
    Burkhardt, Birgit
    Bodmer, Nicole
    Boos, Joachim
    Cario, Gunnar
    Conter, Valentino
    Flotho, Christian
    Kulozik, Andreas E.
    Lanvers-Kaminsky, Claudia
    Mann, Georg
    Niggli, Felix
    Silvestri, Daniela
    von Stackelberg, Arend
    Stanulla, Martin
    Valsecchi, Maria Grazia
    Zimmermann, Martin
    BLOOD, 2022, 140 : 11676 - 11678
  • [36] Successful treatment of acute lymphoblastic leukemia (ALL) during pregnancy using a pediatric-based protocol incorporating pegylated asparaginase
    Jeffrey, Anthony
    Presgrave, Peter
    Walsh, Colin A.
    Sinn, John
    Kennedy, Debra
    Anazodo, Antoinette
    Kumar, Poomahal
    Osborn, Michael
    Trahair, Toby
    Bradstock, Kenneth
    Dalla-Pozza, Luciano
    Greenwood, Matthew
    LEUKEMIA & LYMPHOMA, 2023, 64 (11) : 1880 - 1883
  • [37] Randomized Comparison of IV PEG and IM E. Coli Asparaginase in Children and Adolescents with Acute Lymphoblastic Leukemia: Results of the DFCI ALL Consortium Protocol 05-01
    Silverman, Lewis B.
    Stevenson, Kristen
    Vrooman, Lynda M.
    Supko, Jeffrey G.
    Asselin, Barbara
    Athale, Uma
    Clavell, Luis A.
    Cole, Peter
    Kelly, Kara M.
    Laverdiere, Caroline
    Michon, Bruno
    Schorin, Marshall A.
    Schwartz, Cindy
    Neuberg, Donna
    Sallan, Stephen E.
    BLOOD, 2011, 118 (21) : 398 - 399
  • [38] Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL)
    Kwok, Cecilia Sze
    Kham, Shirley Kow
    Ariffin, Hany
    Lin, Hai Peng
    Quah, Thuan Chong
    Yeoh, Allen Eng
    PEDIATRIC BLOOD & CANCER, 2006, 47 (03) : 299 - 304
  • [39] Relative toxicity of E-coli L-asparaginase (ASP) and pegasparcase (PEG) in newly diagnosed childhood acute lymphoblastic leukemia (ALL).
    Asselin, B
    Gelber, R
    Sallan, S
    BLOOD, 1995, 86 (10) : 695 - 695
  • [40] COST MINIMIZATION ANALYSIS OF PEG-L-ASPARGINASE VERSUS E.COLI L-ASPARAGINASE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS: A JORDANIAN PERSPECTIVE
    Al Rabayah, A. A.
    Jaddouh, S.
    Amireh, A.
    VALUE IN HEALTH, 2016, 19 (07) : A721 - A722
12345